GRAIL Insider Buying Signals: Board Member’s 329‑Share Grant Boosts Investor Confidence
GRAIL insider buy: Board member Summe’s $32K deferred‑stock grant shows confidence in the company’s liquid‑biopsy pipeline, market access strategy and long‑term growth potential.
3 minutes to read